Table 2 Effect of treatment on blood pressure

From: Role of angiotensin II in plasma PAI-1 changes induced by imidapril or candesartan in hypertensive patients with metabolic syndrome

Time

Imidapril (n=40)

Candesartan (n=39)

Seated SBP mm Hg

 Baseline

149.8±8.4

150.1±8.3

 Week 2

141.2±7.2**

142.1±7.5**

 Week 4

135.3±6.7***

134.9±6.6***

 Week 8

133.2±6.5***

132.4±6.4***

 Week 12

132.1±6.3***

131.7±6.2***

 Week 16

130.4±6.1***

130.6±6.3***

Seated DBP mm Hg

 Baseline

99.1±5.1

98.9±4.9

 Week 2

92.3±4.4**

91.8±4.2**

 Week 4

88.6±4.1***

88.2±3.8***

 Week 8

85.2±3.6***

85.5±3.4***

 Week 12

84.3±3.1***

84.5±3.0***

 Week 16

82.3±2.7***

82.6±2.8***

  1. Abbreviations: DBP, diastolic blood pressure; SBP, systolic blood pressure.
  2. **P<0.01 vs. baseline; ***P<0.001 vs. baseline.
Back to article page